Eye Allergy Therapeutics Market - Global Industry Analysis

Eye Allergy Therapeutics Market By Product (Antihistamines, Mast cell stabilizers, Corticosteroids, Immunomodulators, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Drug Stores), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Predictions 2022 – 2028

Published Date: 03-Aug-2022 Category: Healthcare Report Format : PDF Pages: 206 Report Code: ZMR-6013 Status : Published

The global eye allergy therapeutics market size was worth USD 2,914.1 million in 2021 and is estimated to grow to USD 3,838.7 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.7% over the forecast period.

Description

Industry Perspective

The global eye allergy therapeutics market size was worth USD 2,914.1 million in 2021 and is estimated to grow to USD 3,838.7 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.7% over the forecast period. The report analyzes the eye allergy therapeutics market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the eye allergy therapeutics market.

Eye Allergy Therapeutics Market: Overview

Allergies to the eyes, also known as allergic conjunctivitis, are quite common. Anything that irritates the eyes is a type of allergen. To combat allergens, the eyes release histamine. Conjunctiva and eyes become irritated, inflamed, and red as a result. Unlike other types of conjunctivitis, eye allergies do not transfer from person to person. The body's immune system might also react to an allergen that is often harmless, leading to the development of an allergy. Growing aging populations and changing lifestyles are boosting the rising prevalence of ophthalmological problems, which is one of the protuberant drivers promoting the growth of the global market for eye allergy therapeutics. Favorable government funding from developed and a few developing nations support ocular problem research and prevention programs at several public and private organizations. However, the global market for eye allergy therapeutics is being constrained by issues such as a shortage of skilled specialists, a lack of awareness, and the side effects of numerous medications.

Global Eye Allergy Therapeutics Market

COVID-19 Impact:

Several countries around the world enacted tight lockdown and stay-at-home policies to stop the spread of the virus. This caused an abrupt drop in ophthalmologist visits, which in turn hampered the uptake of eye allergy therapies and revenue realization. Severe eye allergies may frequently require prescription medications as far as therapy patterns go. As the treatment continues, consultations with ophthalmologists are frequently needed. As a result, the COVID-19 pandemic has had a detrimental effect on the global eye allergy therapeutics market's growth because the global lockdowns have reduced ophthalmologist visits.

Key Insights

  • The global eye allergy therapeutics market value is predicted to grow at a CAGR of 4.7% over the forecast period.
  • In terms of revenue, the global eye allergy therapeutics market size was valued at around USD 2,914.1 million in 2021 and is projected to reach USD 3,838.7 million by 2028.
  • The worldwide eye allergy therapeutics market has been growing due to improvements in ophthalmology.
  • During the forecast period, North America, which has the biggest share of 40.4% in 2021, is expected to increase at a significant CAGR.
  • The antihistamines category is predicted to grow at the fastest rate during the forecast period.
  • In 2021, hospital pharmacies significantly contributed to the expansion of the global market for eye allergy therapeutics.

Eye Allergy Therapeutics Market: Growth Drivers

The expanding patient population is driving the demand for eye allergy therapeutics market

The considerable patient population suffering from eye allergies is one of the most important and significant key drivers of the global market growth. Over 15% of the world's population is affected by allergies. With an allergic propensity that tends to impact several body organs, the patient may have symptoms that pertain to many organs. However, the ocular component is thought to be the most noticeable and incapacitating aspect of an allergy since it causes chronic symptoms, such as eye itching and watering, which causes severe discomfort. With the significant increase in the patient population over the past few years, the demand for medicines used for treating conditions like antihistamines and mast cell stabilizers has expanded dramatically. Numerous studies have shown that during the past 40 years, the prevalence of this issue has significantly grown. This element is anticipated to fuel global eye allergy therapeutics market expansion.

Eye Allergy Therapeutics Market: Restraints

Market growth is hampered by a lack of knowledge about eye allergies and adverse drug reactions

The general public is unaware of eye problems and eye health, despite a crucial and growing demand for eye allergy therapies. The varied symptoms of eye allergies and other ocular disorders, which can be treated or corrected quickly with accurate diagnoses and treatments, are not well understood. Ophthalmologists are not frequently consulted by patients unless there is a serious clinical problem. Most of the time, eye allergy symptoms like persistent itching are disregarded and improperly diagnosed, significantly lowering the number of patients who may be effectively treated with prescription medications. One of the key factors limiting the expansion of the global market is adverse treatment effects. While most of the time, patients do not encounter fatal or life-threatening symptoms, certain unfavorable effects, including eye irritation, burning, headaches, runny or stuffy noses, difficulty in breathing, and increased sensitivity to light, may happen. Therefore, these issues could lead to incorrect self-diagnosis and prevent these therapies from being used widely, resulting in slower market expansion throughout the projection period.

Eye Allergy Therapeutics Market: Segmentation

The global eye allergy therapeutics market is segregated on the basis of product, distribution channels, and region.

By product, the market is divided into antihistamines, mast cell stabilizers, corticosteroids, immunomodulators, and others. Antihistamines are known as the standard gold treatment for eye allergy. Hence, this segment is expected to expand at the fastest rate over the projected period. One of the main factors influencing the development of antihistamine medications is the increased incidence of allergic responses worldwide. The growth rate of the antihistamine medicine market is propelled by the increase in healthcare spending. The antihistamine medications market is also expected to grow due to growing public and private activities to raise awareness about treating diverse allergic reactions. The distribution channel divides the global eye allergy therapeutics market into hospital pharmacies, online pharmacies, and drug stores. It is anticipated that the hospital pharmacies segment will hold the greatest market share during the projected period. The bulk of eye allergy drugs may only be administered after extensive examinations by qualified medical specialists at these institutes, contributing to the segment's dominance.

Recent Developments

  • In February 2021, Alcon, a worldwide leader in eye care, said that Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following FDA approval for over-the-counter sale in 2020.
  • In February 2021, Bausch + Lomb, a leading worldwide eye health company of Bausch Health Companies Inc., announced the U.S. launch of Alaway Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops, the first and only OTC preservative-free antihistamine eye itch relief drop approved by the U.S.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Eye Allergy Therapeutics Market: Regional Landscape

North America will dominate the market due to increased awareness regarding ocular health

In 2021, North America dominated the global eye allergy therapeutics market due to the United States' significant advancements in ophthalmology. This is due to the region's high prevalence of eye allergies, extensive knowledge of the condition, and the presence of substantial factors that have led to the introduction of cutting-edge medications. In addition, rising government initiatives are also fueling the eye allergy therapeutic market's expansion.

Eye Allergy Therapeutics Market: Competitive Landscape

Some of the main competitors dominating the global eye allergy therapeutics market include - Allergan Plc, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Allergy Therapeutics, and Akorn Inc.

Global Eye Allergy Therapeutics Market is segmented as follows:

By Product

  • Antihistamines
  • Mast cell stabilizers
  • Corticosteroids
  • Immunomodulators
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacy
  • Drug Stores

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Eye Allergy Therapeutics Market, (2022 - 2028) (USD Million)
    • 2.2 Global Eye Allergy Therapeutics Market : snapshot
  • Chapter 3. Global Eye Allergy Therapeutics Market - Industry Analysis
    • 3.1 Eye Allergy Therapeutics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The expanding patient population is driving the demand for eye allergy therapeutics market
    • 3.3 Market Restraints
      • 3.3.1. Market growth is hampered by a lack of knowledge about eye allergies and adverse drug reactions
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Eye Allergy Therapeutics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Eye Allergy Therapeutics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Eye Allergy Therapeutics Market - Product Analysis
    • 5.1 Global Eye Allergy Therapeutics Market overview: By Product
      • 5.1.1 Global Eye Allergy Therapeutics Market share, By Product, 2021 and 2028
    • 5.2 Antihistamines
      • 5.2.1 Global Eye Allergy Therapeutics Market by Antihistamines, 2022 - 2028 (USD Million)
    • 5.3 Mast cell stabilizers
      • 5.3.1 Global Eye Allergy Therapeutics Market by Mast cell stabilizers, 2022 - 2028 (USD Million)
    • 5.4 Corticosteroids
      • 5.4.1 Global Eye Allergy Therapeutics Market by Corticosteroids, 2022 - 2028 (USD Million)
    • 5.5 Immunomodulators
      • 5.5.1 Global Eye Allergy Therapeutics Market by Immunomodulators, 2022 - 2028 (USD Million)
    • 5.6 Others
      • 5.6.1 Global Eye Allergy Therapeutics Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Eye Allergy Therapeutics Market - Distribution Channel Analysis
    • 6.1 Global Eye Allergy Therapeutics Market overview: By Distribution Channel
      • 6.1.1 Global Eye Allergy Therapeutics Market share, By Distribution Channel, 2021 and 2028
    • 6.2 Hospital Pharmacies
      • 6.2.1 Global Eye Allergy Therapeutics Market by Hospital Pharmacies, 2022 - 2028 (USD Million)
    • 6.3 Online Pharmacy
      • 6.3.1 Global Eye Allergy Therapeutics Market by Online Pharmacy, 2022 - 2028 (USD Million)
    • 6.4 Drug Stores
      • 6.4.1 Global Eye Allergy Therapeutics Market by Drug Stores, 2022 - 2028 (USD Million)
  • Chapter 7. Eye Allergy Therapeutics Market - Regional Analysis
    • 7.1 Global Eye Allergy Therapeutics Market Regional Overview
    • 7.2 Global Eye Allergy Therapeutics Market Share, by Region, 2021 & 2028 (USD Million)
    • 7.3. North America
      • 7.3.1 North America Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
        • 7.3.1.1 North America Eye Allergy Therapeutics Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 North America Eye Allergy Therapeutics Market, by Product, 2022 - 2028
      • 7.4.1 North America Eye Allergy Therapeutics Market, by Product, 2022 - 2028 (USD Million)
    • 7.5 North America Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028
      • 7.5.1 North America Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 7.4. Europe
      • 7.4.2 Europe Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
        • 7.4.2.1 Europe Eye Allergy Therapeutics Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Europe Eye Allergy Therapeutics Market, by Product, 2022 - 2028
      • 7.4.1 Europe Eye Allergy Therapeutics Market, by Product, 2022 - 2028 (USD Million)
    • 7.5 Europe Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028
      • 7.5.1 Europe Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
        • 7.5.3.1 Asia Pacific Eye Allergy Therapeutics Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Asia Pacific Eye Allergy Therapeutics Market, by Product, 2022 - 2028
      • 7.4.1 Asia Pacific Eye Allergy Therapeutics Market, by Product, 2022 - 2028 (USD Million)
    • 7.5 Asia Pacific Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028
      • 7.5.1 Asia Pacific Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 7.6. Latin America
      • 7.6.4 Latin America Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
        • 7.6.4.1 Latin America Eye Allergy Therapeutics Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 Latin America Eye Allergy Therapeutics Market, by Product, 2022 - 2028
      • 7.4.1 Latin America Eye Allergy Therapeutics Market, by Product, 2022 - 2028 (USD Million)
    • 7.5 Latin America Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028
      • 7.5.1 Latin America Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Million)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
        • 7.7.5.1 The Middle-East and Africa Eye Allergy Therapeutics Market, by Country, 2022 - 2028 (USD Million)
    • 7.4 The Middle-East and Africa Eye Allergy Therapeutics Market, by Product, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Eye Allergy Therapeutics Market, by Product, 2022 - 2028 (USD Million)
    • 7.5 The Middle-East and Africa Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Eye Allergy Therapeutics Market, by Distribution Channel, 2022 - 2028 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1 Allergan Plc
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Bausch Health Companies Inc.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Novartis AG
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Santen Pharmaceutical Co. Ltd.
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Allergy Therapeutics
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Akorn Inc.
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Eye Allergy Therapeutics Market attractiveness, By Product
  • 6. Global Eye Allergy Therapeutics Market attractiveness, By Distribution Channel
  • 7. Global Eye Allergy Therapeutics Market share by Product, 2022 and 2028 (USD Million)
  • 8. Global Eye Allergy Therapeutics Market by Antihistamines, 2022 - 2028 (USD Million)
  • 9. Global Eye Allergy Therapeutics Market by Mast cell stabilizers, 2022 - 2028 (USD Million)
  • 10. Global Eye Allergy Therapeutics Market by Corticosteroids, 2022 - 2028 (USD Million)
  • 11. Global Eye Allergy Therapeutics Market by Immunomodulators, 2022 - 2028 (USD Million)
  • 12. Global Eye Allergy Therapeutics Market by Others, 2022 - 2028 (USD Million)
  • 13. Global Eye Allergy Therapeutics Market share by Distribution Channel, 2022 and 2028 (USD Million)
  • 14. Global Eye Allergy Therapeutics Market by Hospital Pharmacies, 2022 - 2028 (USD Million)
  • 15. Global Eye Allergy Therapeutics Market by Online Pharmacy, 2022 - 2028 (USD Million)
  • 16. Global Eye Allergy Therapeutics Market by Drug Stores, 2022 - 2028 (USD Million)
  • 17. Global Eye Allergy Therapeutics Market share, by Region, 2022 and 2028
  • 18. North America Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
  • 19. Europe Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
  • 20. Asia Pacific Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
  • 21. Latin America Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)
  • 22. The Middle-East and Africa Eye Allergy Therapeutics Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Eye Allergy Therapeutics Market: Snapshot
  • 2. Drivers of the Eye Allergy Therapeutics Market: impact analysis
  • 3. North America Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 4. North America Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 5. U.S. Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 6. U.S. Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 7. Canada Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 8. Canada Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 9. Europe Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 10. Europe Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 11. Germany Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 12. Germany Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 13. France Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 14. France Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 15. U.K. Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 16. U.K. Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 17. Italy Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 18. Italy Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 19. Spain Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 20. Spain Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 21. Rest of Europe Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 22. Rest of Europe Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 23. Asia Pacific Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 24. Asia Pacific Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 25. China Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 26. China Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 27. Japan Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 28. Japan Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 29. India Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 30. India Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 31. South Korea Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 32. South Korea Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 33. South-East Asia Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 34. South-East Asia Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 35. Rest of Asia Pacific Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 36. Rest of Asia Pacific Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 37. Latin America Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 38. Latin America Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 39. Brazil Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 40. Brazil Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 41. Mexico Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 42. Mexico Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 43. Rest of Latin America Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 44. Rest of Latin America Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 45. The Middle-East and Africa Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 46. The Middle-East and Africa Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 47. GCC Countries Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 48. GCC Countries Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 49. South Africa Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 50. South Africa Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)
  • 51. Rest of Middle-East Africa Eye Allergy Therapeutics Market revenue, By Product, 2022 - 2028 (USD Million)
  • 52. Rest of Middle-East Africa Eye Allergy Therapeutics Market revenue, By Distribution Channel, 2022 - 2028 (USD Million)

Methodology

Choose License Type

FrequentlyAsked Questions

Growing aging populations and changing lifestyles are boosting the rising prevalence of ophthalmological problems, one of the protuberant drivers promoting the growth of the global market for eye allergy therapy.

According to the report, the global eye allergy therapeutics market was worth 2,914.1 (USD million) in 2021 and is predicted to grow to 3,838.7 (USD million) by 2028, with a compound annual growth rate (CAGR) of around 4.7%.

North America is anticipated to dominate the industry globally due to the United States' significant advancements in ophthalmology. This is due to the region's high prevalence of eye allergies, extensive knowledge of the condition, and the presence of substantial factors that have led to the introduction of cutting-edge medications.

Some of the main competitors dominating the global eye allergy therapeutics market include - Allergan Plc, Bausch Health Companies Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Allergy Therapeutics, and Akorn Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed